Barrett's esophagus, fundoplication, and cancer

World Journal of Surgery

Volumn 31, Issue 3, 2007, Pages 447-449

  Watson, David I ^a   Mayne, George C ^a   Hussey, Damian J ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; BILE REFLUX; CANCER GROWTH; CANCER RISK; DUODENOGASTRIC REFLUX; EDITORIAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL PH MONITORING; ESOPHAGUS MUCOSA; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HUMAN; PANCREAS JUICE; STOMACH ACID SECRETION; STOMACH FUNDOPLICATION; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; BILE ACIDS AND SALTS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; INCIDENCE; RISK ASSESSMENT; TREATMENT FAILURE; TUMOR MARKERS, BIOLOGICAL;

EID: 33847672834     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-006-0822-x     Document Type: Editorial

References (10)

1. Dixon MF, Neville PM, Mapstone NP, Moayyedi P, Axon AT. Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux? Gut 2001;49:359-363.
2. Hammer J, Schmidt B. Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough. Alimentary Pharmacology & Therapeutics 2004;19:1105-1110.
3. Olliver JR, Hardie LJ, Dexter S, Chalmers D, Wild CP. DNA damage levels are raised in Barrett's oesophageal mucosa relative to the squamous epithelium of the oesophagus. Biomarkers 2003;8:509-521.
4. Todd JA, Basu KK, de Caestecker JS. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus. Aliment Pharmacol Ther 2005;21:969-975.
5. Jolly AJ, Wild CP, Hardie LJ. Acid and bile salts induce DNA damage in human oesophageal cell lines. Mutagenesis 2004;19:319-324.
6. Hofstetter WL, Peters JH, DeMeester TR, Hagen JA, DeMeester SR, Crookes PF, Tsai P, Banki F, Bremner CG. Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg 2001;234:532-538.
7. O'Riordan JM, Byrne PJ, Ravi N, Keeling PW, Reynolds JV. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery. Am J Surg 2004;188:27-33.
8. Rantanen TK, Rasanen JV, Sihvo EI, Ahotupa MO, Farkkila MA, Salo JA. The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study. Am J Gastroenterol 2006;101:222-228.
9. Ludemann R, Watson DI, Game PA, Devitt PG, Jamieson GG. Laparoscopic total versus anterior 180o fundoplication - five year follow-up of a prospective randomized trial. Br J Surg 2005;92:240-243.
10. Lagergren J, Viklund P. Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux? World J Surg.